Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

ClinicalTrials.gov ID: NCT00667173

Public ClinicalTrials.gov record NCT00667173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-Center, Evaluator-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-115 in the Treatment of Rosacea

Study identification

NCT ID
NCT00667173
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dow Pharmaceutical Sciences
Industry
Enrollment
140 participants

Conditions and interventions

Conditions

Interventions

  • IDP-115 Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Feb 19, 2012

2007 – 2008

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801
Therapeutics Clinical Research San Diego California 92123
Solano Clinical Research Vallejo California 94589
Cherry Creek Dermatology Research Inc. Denver Colorado 80246
FXM Research Corp. Miami Florida 33175
MedaPhase Inc. Newnan Georgia 30263
Henry Ford Medical Center Detroit Michigan 48202
Academic Dermatology Associates Albuquerque New Mexico 87106
University Dermatology Consultants, Inc. Cincinnati Ohio 45219
DermResearch, Inc. Austin Texas 78759

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00667173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00667173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →